Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies-Reference-Cited by-同舟云学术

Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies

Published:2016-02-06 Issue:4 Volume:35 Page:597-609
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Marotta P.,Bailey R.,Elkashab M.,Farley J.,Feinman S. V.,Peltekian K.,Poliquin M.,Witt-Sullivan H.,Rampakakis E.,Drolet M.,Cooper C.

Funder

Merck Canada Inc.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-016-2576-1.pdf

Reference59 articles.

1. World Health Organization (WHO) (2010) Resolutions from the Sixty-third World Health Assembly (WHA63). WHO

2. Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17(2):107–115

3. Myers RP, Krajden M, Bilodeau M, Kaita K, Marotta P, Peltekian K et al (2014) Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol 28(5):243–250

4. Zou S, Tepper M, El Saadany S (2000) Prediction of hepatitis C burden in Canada. Can J Gastroenterol 14(7):575–580

5. Public Health Agency of Canada (PHAC) (2009) Epidemiology of acute hepatitis C infection in Canada: results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sofosbuvir plus ribavirin in Asian patients with chronic genotype 2 hepatitis C virus infection: history of a success?;Liver International;2016-07-12